Immediate Impact

2 by Nobel laureates 7 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
1 intermediate paper

Works of Georg Pall being referenced

Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC)
2020
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
2012

Author Peers

Author Last Decade Papers Cites
Georg Pall 354 189 75 167 49 789
D. Kyriakou 231 98 129 166 44 859
Robert H. Rudolph 263 148 49 195 30 893
Sheeja T. Pullarkat 499 121 47 178 43 955
Byung Soo Kim 321 85 73 102 70 784
Timothy J. O’Rourke 337 209 83 68 33 940
Sandra J. Casak 433 213 108 132 31 964
Bunshiro Akikusa 116 116 43 224 52 819
Vivek R. Sharma 185 122 62 146 49 734
Daniel L. Kisner 246 136 115 188 33 979
B. Vasseur 518 122 107 125 33 869

All Works

Loading papers...

Rankless by CCL
2026